These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 9465882)
1. Unconjugated antibodies for cancer therapy: lessons from the clinic. Ward RL; Hawkins NJ; Smith GM Cancer Treat Rev; 1997; 23(5-6):305-19. PubMed ID: 9465882 [No Abstract] [Full Text] [Related]
2. Possible applications of antibodies or their genes in cancer therapy. Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452 [TBL] [Abstract][Full Text] [Related]
4. Abstracts from the Eleventh Conference on Cancer Therapy with Antibodies and Immunoconjugates. October 12-14, 2006. Parsippany, New Jersey, USA. Cancer Biother Radiopharm; 2006 Aug; 21(4):382-405. PubMed ID: 16999603 [No Abstract] [Full Text] [Related]
5. Recombinant antibodies: from the laboratory to the clinic. Albrecht H; DeNardo SJ Cancer Biother Radiopharm; 2006 Aug; 21(4):285-304. PubMed ID: 16999595 [TBL] [Abstract][Full Text] [Related]
6. Recruiting dendritic cells to improve antibody therapy of cancer. Dhodapkar KM; Dhodapkar MV Proc Natl Acad Sci U S A; 2005 May; 102(18):6243-4. PubMed ID: 15851655 [No Abstract] [Full Text] [Related]
8. Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection. Stiegler G; Katinger H J Antimicrob Chemother; 2003 Apr; 51(4):757-9. PubMed ID: 12654737 [No Abstract] [Full Text] [Related]
9. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. Schenk D Nat Rev Neurosci; 2002 Oct; 3(10):824-8. PubMed ID: 12360327 [No Abstract] [Full Text] [Related]
10. Development of antibodies and chimeric molecules for cancer immunotherapy. Waldmann TA; Morris JC Adv Immunol; 2006; 90():83-131. PubMed ID: 16730262 [TBL] [Abstract][Full Text] [Related]
11. The promise of monoclonal antibodies for the therapy of cancer. Gutheil J Crit Rev Oncol Hematol; 2001 Apr; 38(1):1-2. PubMed ID: 11255076 [No Abstract] [Full Text] [Related]
12. [New antibodies in cancer treatment]. Pestalozzi BC; Knuth A Praxis (Bern 1994); 2004 Sep; 93(39):1589-92. PubMed ID: 15500243 [TBL] [Abstract][Full Text] [Related]
13. Applications of molecular biology and biotechnology: antibody therapy of sepsis. Wheeler AP; Bernard GR J Crit Care; 1996 Jun; 11(2):77-94. PubMed ID: 8727029 [TBL] [Abstract][Full Text] [Related]
14. Active and passive immunotherapy: vaccines and antibodies. Oosterwijk E; Divgi C; Bander NH BJU Int; 2007 May; 99(5 Pt B):1301-4. PubMed ID: 17441928 [No Abstract] [Full Text] [Related]
15. Cancer immunotherapy of targeting angiogenesis. Hou J; Tian L; Wei Y Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162 [TBL] [Abstract][Full Text] [Related]
18. Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies. Iannello A; Ahmad A Cancer Metastasis Rev; 2005 Dec; 24(4):487-99. PubMed ID: 16408158 [TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of passive immunoprophylaxis in paediatric patients at risk of severe RSV infection. Pons JM; Tebé C; Paladio N; Garcia-Altes A; Danés I; Valls-I-Soler A Acta Paediatr; 2011 Mar; 100(3):324-9. PubMed ID: 20950412 [TBL] [Abstract][Full Text] [Related]
20. Improving the efficacy of antibody-based cancer therapies. Carter P Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]